Monitoring essential medicines access-unfinished business

Affiliations

¹ WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa. Electronic address: graya1@ukzn.ac.za.
² WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.

Free article

Andrew Lofts Gray et al. Lancet Glob Health. 2025 Jan.

Free article

. 2025 Jan;13(1):e4-e5.

doi: 10.1016/S2214-109X(24)00483-2.

¹ WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa. Electronic address: graya1@ukzn.ac.za.
² WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.

No abstract available

Conflict of interest statement

ALG declares being the co-chair of the WHO Technical Advisory Group on Pricing Policies for Medicines. FS declares no competing interests.